European citizens hold more finely differentiated and balanced views on genetically modified foods than scientists and politicians give them credit for, says a study carried out for the European Commission.
False interpretations of what the public wants are largely responsible for the difficulties faced by European policy-makers in managing agricultural biotechnology, the study claims.
The study, Public Perceptions of Agricultural Biotechnologies in Europe, is based on an analysis of discussions held between 1998 and 2000 by 55 focus groups in Germany, France, Britain, Italy and Spain, as well as interviews with activists, scientists and others who are more directly involved with the agricultural biotechnology industry. It was coordinated by Brian Wynne, a sociologist at Lancaster University, UK, who established his reputation by using such methods to assess the public's perception of nuclear power in the 1980s.
"Almost all popular opinions on the alleged misperceptions about the alleged view of the 'man and woman on the street' turned out to be simply myths," the study says. "Participants did not, overall, express entrenched opinions 'for' or 'against' genetically modified organisms."
The researchers found that public mistrust of regulatory bodies such as food-safety agencies was the underlying basis of suspicions of agricultural biotechnology.
Better information will not, in itself, restore the public's trust in these regulators, the study concludes. Instead, it says that "more profound changes in institutional culture and practice" will be required. It suggests imposing heavy sanctions on companies or research institutions if any harm is caused by new technologies.
But Derek Burke, a retired molecular biologist and former chairman of the UK Advisory Committee on Novel Food and Processes, is sceptical about the study's findings, saying that he is uneasy about both its tone and its content. Burke argues that focus groups can easily be led towards a desired conclusion.
"This is an interesting contribution from a group of people with strong views," says Burke. "But their arguments reflect no more than the current media coverage." allegations, Schön says that he is cooperating fully with the review committee. "I'm collaborating with my colleagues to reproduce these results and show them to the committee," he says. "I am trying to focus on the science."
At 31 years old, Schön is seen as one of the most able young physicists in nanotechnology. In the six years since he got his PhD at the University of Konstanz in Germany, he has produced over 100 papers and claimed several patents, as well as winning awards for his work in both the United States and Germany.
The speed and scope of his findings have aroused admiration among researchers -but some of his results have proved hard to reproduce. Robert Dynes at the University of California, San Diego, for example, has tried to replicate some of Schön's results for molecular switches that are turned on and off when an electric field is applied. "I was fascinated by the results and frustrated that I couldn't reproduce them, and I didn't totally understand why I couldn't," recalls Dynes. The problem, he says, was that the applied electric field kept destroying critical components of the experiment.
Dynes is not alone. Groups at the French Atomic Energy Commission, Harvard University, Princeton and elsewhere say that they have so far been unable to reproduce some of Schön's results. 
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The US National Science Foundation (NSF) is under fire over its financial management of major research projects -including its contribution to the Large Hadron Collider, the particle collider being built at CERN, the European particle-physics laboratory in Geneva.
An audit by the research agency's inspector general, Christine Boesz, found that the NSF failed to track properly the full costs of the projects. For example, the agency told the National Science Board, its governing body, that its contribution to detectors at the Large Hadron Collider would cost $81 million. But, the audit says, a further $57 million will be needed for advanced computing and maintenance if US scientists are to glean any data from the detectors.
" A preliminary version of the software covering well-defined, covalently bonded organic molecules was released this year to let other chemists test the idea. It labels each atom in a compound in a way that does not depend on how the structure is drawn, and converts the label to a string of characters. The format has not been finalized, but at present ethane is 'C3C3, 2-1' , for example, and acetone is 'C3C3OC, 4-1-2-3' (the labels are easily converted to structures using the algorithm). The process is reversible, so molecular structures can be generated from the identifiers. The next step is to extend the system to include more complex organic compounds, such as polymers, and ultimately to tackle inorganic compounds. By adding it to software packages commonly used to draw chemical structures, the NIST team hopes that IChI will enter into widespread use.
In effect, the IChI number will provide each chemical molecule with a digital object identifier (DOI) -a concept increasingly being applied to everything from scientific papers to individual genes. Jonathan Goodman, a chemist at the University of Cambridge, says chemistry suits this approach well. "Molecules are a wonderful unit of information to treat in this way," he says. 
